Your browser doesn't support javascript.
loading
Cytotoxic effect of cisplatin with proteasome inhibitor on osteosarcoma cells / 浙江大学学报·医学版
Article de Zh | WPRIM | ID: wpr-355196
Bibliothèque responsable: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the cytotoxic effect of cisplatin with proteasome inhibitor on osteosarcoma cells.</p><p><b>METHODS</b>Cell survival was tested by MTT, apoptotic morphology was observed by electron microscopy, apoptotic rate was analyzed by flow cytometry, the transcription level of excision repair cross complementation-1 (ERCC-1) was tested by reverse transcription polymerase reaction.</p><p><b>RESULTS</b>Compared with cells treated with cisplatin alone, cells treated with cisplatin and proteasome inhibitor showed a decreased survival rate, more typical apoptotic morphology, higher apoptotic rate [(14.37 +/-2.37)% vs. (50.93 +/-4.84)%, P<0.01)], and lower transcription level of excision repair cross complementation-1.</p><p><b>CONCLUSION</b>Proteasome inhibitor could increase the cytotoxic effect of cisplatin on osteosarcoma cells and promote cisplatin-induced osteosarcoma apoptosis. These effects may be associated with the decreased transcription of excision repair cross complementation-1.</p>
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Oligopeptides / Anatomopathologie / Pharmacologie / Tumeurs osseuses / Cellules cancéreuses en culture / Ostéosarcome / Cisplatine / Apoptose / Synergie des médicaments / Antinéoplasiques Limites du sujet: Animals langue: Zh Texte intégral: Journal of Zhejiang University. Medical sciences Année: 2005 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Oligopeptides / Anatomopathologie / Pharmacologie / Tumeurs osseuses / Cellules cancéreuses en culture / Ostéosarcome / Cisplatine / Apoptose / Synergie des médicaments / Antinéoplasiques Limites du sujet: Animals langue: Zh Texte intégral: Journal of Zhejiang University. Medical sciences Année: 2005 Type: Article